Global Peripheral Stent Grafts Market Size By Type (AAA Stent Graft, TAA Stent Graft), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Peripheral Stent Grafts Market was valued at USD 1.62 billion in 2023 and is projected to reach USD 3.09 billion by 2031, growing at a CAGR of 8.4% during the forecast period from 2023 to 2031. This growth is driven by the rising incidence of peripheral artery disease (PAD), increased adoption of minimally invasive procedures, and technological advancements in stent graft design and materials. Peripheral stent grafts are increasingly used in treating aneurysms and arterial blockages in limbs, offering improved patient outcomes and reduced recovery times.

Drivers:

1. Increasing Prevalence of Peripheral Artery Disease (PAD):

Rising cases of PAD, especially among the aging population and individuals with diabetes or hypertension, are significantly boosting demand for peripheral stent grafts.

2. Technological Advancements in Stent Graft Materials:

New-generation stent grafts with enhanced flexibility, biocompatibility, and longer durability are expanding treatment options and improving clinical outcomes.

3. Rising Demand for Minimally Invasive Surgeries:

Patient and physician preference for minimally invasive procedures is spurring the adoption of endovascular techniques that utilize stent grafts.

Restraints:

1. High Procedure Costs and Reimbursement Challenges:

Despite their efficacy, the high cost of stent graft devices and uneven reimbursement policies in some regions can hinder market growth.

2. Risk of Complications and Product Failures:

Issues like endoleaks, stent migration, or graft thrombosis may limit broader acceptance and require continuous product innovation and physician training.

Opportunity:

1. Expanding Geriatric Population and Lifestyle Diseases:

The global rise in elderly demographics and associated cardiovascular risks presents a substantial opportunity for peripheral stent graft usage.

2. Emerging Markets and Infrastructure Investments:

Developing economies, especially in Asia-Pacific and Latin America, are improving their healthcare infrastructure and adopting advanced vascular treatments, opening new growth avenues.

Market by System Type Insights:

The Balloon-Expandable Stent Grafts segment led the market in 2023, driven by its precise deployment capabilities in complex anatomies. However, the Self-Expanding Stent Grafts segment is expected to register the fastest growth rate during the forecast period due to its adaptability in tortuous vessels and better conformability.

Market by End-use Insights:

Hospitals held the largest market share in 2023, accounting for more than 55% of the total revenue. The availability of skilled interventional radiologists and advanced vascular imaging tools in hospitals makes them the primary site for peripheral stent graft procedures. Ambulatory Surgical Centers (ASCs) are anticipated to witness significant growth due to faster procedural turnover, reduced costs, and increased preference for outpatient care.

Market by Regional Insights:

North America dominated the market in 2023, attributed to high PAD prevalence, strong healthcare infrastructure, and early adoption of new stent technologies. However, Asia-Pacific is projected to experience the highest CAGR through 2031, fueled by a growing patient population, rising awareness, and improving access to endovascular care in countries like China and India.

Competitive Scenario:

Prominent players in the global peripheral stent grafts market include Medtronic plc, W. L. Gore & Associates, Cook Medical, BD (Becton, Dickinson and Company), Abbott Laboratories, Terumo Corporation, Bentley InnoMed GmbH, and Endologix LLC. These companies are engaging in strategic product launches, regulatory approvals, and geographic expansion to enhance their market footprint.

Key Market Developments:

Medtronic introduced a next-gen stent graft in 2024 with enhanced radial strength for femoropopliteal lesions.

W. L. Gore received FDA approval in 2023 for its new low-profile stent graft optimized for tortuous anatomy.

Cook Medical announced a strategic partnership in 2025 to expand its distribution in Southeast Asia.

Scope of Work – Global Peripheral Stent Grafts Market

Report Metric Details

Market Size (2023) USD 1.62 billion

Projected Market Size (2031) USD 3.09 billion

CAGR (2023–2031) 8.4%

Market Segments System Type (Balloon-Expandable, Self-Expanding), End-use (Hospitals, ASCs), Region

Growth Drivers Increasing PAD prevalence, Technological advancements, Rising demand for minimally invasive surgery

Opportunities Emerging markets, Geriatric population growth, Infrastructure investments

FAQs:

1) What is the current market size of the Global Peripheral Stent Grafts Market?

The market size in 2023 was valued at USD 1.62 billion.

2) What is the major growth driver of the Global Peripheral Stent Grafts Market?

The primary growth driver is the increasing prevalence of peripheral artery disease and growing adoption of minimally invasive procedures.

3) Which is the largest region during the forecast period in the Global Peripheral Stent Grafts Market?

North America currently leads, but Asia-Pacific is expected to register the highest growth rate through 2031.

4) Which segment accounted for the largest market share in the Global Peripheral Stent Grafts Market?

Hospitals held the largest market share in 2023 due to advanced infrastructure and skilled personnel.

5) Who are the key market players in the Global Peripheral Stent Grafts Market?

Leading players include Medtronic plc, W. L. Gore & Associates, Cook Medical, BD, Abbott, Terumo Corporation, and Endologix LLC.